389 related articles for article (PubMed ID: 33622481)
1. Severe Acute Respiratory Syndrome Coronavirus 2 Seropositivity among Healthcare Personnel in Hospitals and Nursing Homes, Rhode Island, USA, July-August 2020.
Akinbami LJ; Chan PA; Vuong N; Sami S; Lewis D; Sheridan PE; Lukacs SL; Mackey L; Grohskopf LA; Patel A; Petersen LR
Emerg Infect Dis; 2021 Mar; 27(3):823-834. PubMed ID: 33622481
[TBL] [Abstract][Full Text] [Related]
2. SARS-CoV-2 Seroprevalence among Healthcare, First Response, and Public Safety Personnel, Detroit Metropolitan Area, Michigan, USA, May-June 2020.
Akinbami LJ; Vuong N; Petersen LR; Sami S; Patel A; Lukacs SL; Mackey L; Grohskopf LA; Shehu A; Atas J
Emerg Infect Dis; 2020 Dec; 26(12):2863-2871. PubMed ID: 32956614
[TBL] [Abstract][Full Text] [Related]
3. SARS-CoV-2 Seroprevalence Among Healthcare Workers by Workplace Exposure Risk in Kashmir, India.
Khan MS; Haq I; Qurieshi MA; Majid S; Bhat AA; Qazi TB; Chowdri IN; Sabah I; Kawoosa MF; Lone AA; Nabi S; Sumji IA; Obaid M; Kousar R
J Hosp Med; 2021 May; 16(5):274-281. PubMed ID: 33929947
[TBL] [Abstract][Full Text] [Related]
4. Risk Factors Associated With SARS-CoV-2 Seropositivity Among US Health Care Personnel.
Jacob JT; Baker JM; Fridkin SK; Lopman BA; Steinberg JP; Christenson RH; King B; Leekha S; O'Hara LM; Rock P; Schrank GM; Hayden MK; Hota B; Lin MY; Stein BD; Caturegli P; Milstone AM; Rock C; Voskertchian A; Reddy SC; Harris AD
JAMA Netw Open; 2021 Mar; 4(3):e211283. PubMed ID: 33688967
[TBL] [Abstract][Full Text] [Related]
5. Seroprevalence of SARS-CoV-2 antibodies in healthcare workers at a London NHS Trust.
Grant JJ; Wilmore SMS; McCann NS; Donnelly O; Lai RWL; Kinsella MJ; Rochford HL; Patel T; Kelsey MC; Andrews JA
Infect Control Hosp Epidemiol; 2021 Feb; 42(2):212-214. PubMed ID: 32746953
[TBL] [Abstract][Full Text] [Related]
6. Seroprevalence of severe acute respiratory syndrome coronavirus-2 (SARS-CoV-2) infection among Veterans Affairs healthcare system employees suggests higher risk of infection when exposed to SARS-CoV-2 outside the work environment.
Dimcheff DE; Schildhouse RJ; Hausman MS; Vincent BM; Markovitz E; Chensue SW; Deng J; McLeod M; Hagan D; Russell J; Bradley SF
Infect Control Hosp Epidemiol; 2021 Apr; 42(4):392-398. PubMed ID: 32962771
[TBL] [Abstract][Full Text] [Related]
7. Prevalence of SARS-CoV-2 Antibodies in First Responders and Public Safety Personnel, New York City, New York, USA, May-July 2020.
Sami S; Akinbami LJ; Petersen LR; Crawley A; Lukacs SL; Weiss D; Henseler RA; Vuong N; Mackey L; Patel A; Grohskopf LA; Morgenthau BM; Daskalakis D; Pathela P
Emerg Infect Dis; 2021 Mar; 27(3):796-804. PubMed ID: 33493106
[TBL] [Abstract][Full Text] [Related]
8. Demographic and occupational determinants of anti-SARS-CoV-2 IgG seropositivity in hospital staff.
Martin CA; Patel P; Goss C; Jenkins DR; Price A; Barton L; Gupta P; Zaccardi F; Jerina H; Duraisingham S; Brunskill NJ; Khunti K; Pareek M
J Public Health (Oxf); 2022 Jun; 44(2):234-245. PubMed ID: 33200200
[TBL] [Abstract][Full Text] [Related]
9. Quantification of Occupational and Community Risk Factors for SARS-CoV-2 Seropositivity Among Health Care Workers in a Large U.S. Health Care System.
Baker JM; Nelson KN; Overton E; Lopman BA; Lash TL; Photakis M; Jacob JT; Roback JD; Fridkin SK; Steinberg JP
Ann Intern Med; 2021 May; 174(5):649-654. PubMed ID: 33513035
[TBL] [Abstract][Full Text] [Related]
10. Risk of COVID-19 in health-care workers in Denmark: an observational cohort study.
Iversen K; Bundgaard H; Hasselbalch RB; Kristensen JH; Nielsen PB; Pries-Heje M; Knudsen AD; Christensen CE; Fogh K; Norsk JB; Andersen O; Fischer TK; Jensen CAJ; Larsen M; Torp-Pedersen C; Rungby J; Ditlev SB; Hageman I; Møgelvang R; Hother CE; Gybel-Brask M; Sørensen E; Harritshøj L; Folke F; Sten C; Benfield T; Nielsen SD; Ullum H
Lancet Infect Dis; 2020 Dec; 20(12):1401-1408. PubMed ID: 32758438
[TBL] [Abstract][Full Text] [Related]
11. Non-occupational and occupational factors associated with specific SARS-CoV-2 antibodies among hospital workers - A multicentre cross-sectional study.
Kahlert CR; Persi R; Güsewell S; Egger T; Leal-Neto OB; Sumer J; Flury D; Brucher A; Lemmenmeier E; Möller JC; Rieder P; Stocker R; Vuichard-Gysin D; Wiggli B; Albrich WC; Babouee Flury B; Besold U; Fehr J; Kuster SP; McGeer A; Risch L; Schlegel M; Friedl A; Vernazza P; Kohler P
Clin Microbiol Infect; 2021 Sep; 27(9):1336-1344. PubMed ID: 34020033
[TBL] [Abstract][Full Text] [Related]
12. Associations of BNT162b2 vaccination with SARS-CoV-2 infection and hospital admission and death with covid-19 in nursing homes and healthcare workers in Catalonia: prospective cohort study.
Cabezas C; Coma E; Mora-Fernandez N; Li X; Martinez-Marcos M; Fina F; Fabregas M; Hermosilla E; Jover A; Contel JC; Lejardi Y; Enfedaque B; Argimon JM; Medina-Peralta M; Prieto-Alhambra D
BMJ; 2021 Aug; 374():n1868. PubMed ID: 34407952
[TBL] [Abstract][Full Text] [Related]
13. Seroprevalence of SARS-CoV-2 infection in health care workers of a teaching hospital in Belgium: self-reported occupational and household risk factors for seropositivity.
Scohy A; Gruson D; Simon A; Kabamba-Mukadi B; De Greef J; Belkhir L; Rodriguez-Villalobos H; Robert A; Yombi JC
Diagn Microbiol Infect Dis; 2021 Aug; 100(4):115414. PubMed ID: 34082266
[TBL] [Abstract][Full Text] [Related]
14. Association between SARS-CoV-2 Seroprevalence in Nursing Home Staff and Resident COVID-19 Cases and Mortality: A Cross-Sectional Study.
Wisniak A; Menon LK; Dumont R; Pullen N; Regard S; Dubos R; Zaballa ME; Baysson H; Courvoisier D; Kaiser L; Pittet D; Azman AS; Stringhini S; Guessous I; Balavoine JF; Kherad O; The SEROCoV-Work Study Group
Viruses; 2021 Dec; 14(1):. PubMed ID: 35062247
[TBL] [Abstract][Full Text] [Related]
15. Seroprevalence of SARS-CoV-2 antibodies, associated factors, experiences and attitudes of nursing home and home healthcare employees in Switzerland.
West EA; Kotoun OJ; Schori LJ; Kopp J; Kaufmann M; Rasi M; Fehr J; Puhan MA; Frei A;
BMC Infect Dis; 2022 Mar; 22(1):259. PubMed ID: 35296242
[TBL] [Abstract][Full Text] [Related]
16. Seroprevalence of SARS-CoV-2 (COVID-19) among healthcare workers in Saudi Arabia: comparing case and control hospitals.
Alserehi HA; Alqunaibet AM; Al-Tawfiq JA; Alharbi NK; Alshukairi AN; Alanazi KH; Bin Saleh GM; Alshehri AM; Almasoud A; Hashem AM; Alruwaily AR; Alaswad RH; Al-Mutlaq HM; Almudaiheem AA; Othman FM; Aldakeel SA; Abu Ghararah MR; Jokhdar HA; Algwizani AR; Almudarra SS; Albarrag AM
Diagn Microbiol Infect Dis; 2021 Mar; 99(3):115273. PubMed ID: 33296851
[TBL] [Abstract][Full Text] [Related]
17. Comprehensive infection control measures prevent hospital-acquired severe acute respiratory syndrome coronavirus 2 infection: A single-center prospective cohort study and seroprevalence survey.
Hori H; Fukuchi T; Sanui M; Moriya T; Sugawara H
PLoS One; 2021; 16(10):e0257513. PubMed ID: 34634076
[TBL] [Abstract][Full Text] [Related]
18. What are the sources of exposure in healthcare personnel with coronavirus disease 2019 infection?
Zabarsky TF; Bhullar D; Silva SY; Mana TSC; Ertle MT; Navas ME; Donskey CJ
Am J Infect Control; 2021 Mar; 49(3):392-395. PubMed ID: 32795495
[TBL] [Abstract][Full Text] [Related]
19. Seroprevalence of SARS-CoV-2 IgG antibodies and risk factors in health care workers at an academic medical center in Boston, Massachusetts.
Kataria Y; Cole M; Duffy E; de la Cena K; Schechter-Perkins EM; Bouton TC; Werler MM; Pierre C; Ragan EJ; Weber SE; Jacobson KR; Andry C
Sci Rep; 2021 May; 11(1):9694. PubMed ID: 33958668
[TBL] [Abstract][Full Text] [Related]
20. Pre-Vaccination Anti-Severe Acute Respiratory Syndrome Coronavirus 2 Antibody Seroprevalence in Workers at Three Japanese Hospitals.
Takayama Y; Komatsu T; Wada T; Nihonyanagi S; Hoshiyama T; Moriya T; Shimamura S; Kajigaya N; Naito M; Takeuchi O; Bando Y; Watanabe M; Iwamura M; Hanaki H
J Nippon Med Sch; 2022 Nov; 89(5):513-519. PubMed ID: 35644553
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
